Cardurion Pharmaceuticals has a total of 77 patents globally, out of which 11 have been granted. Of these 77 patents, more than 76% patents are active. The USA is where Cardurion Pharmaceuticals has filed the maximum number of patents, followed by Australia and Canada. Parallelly, the USA seems to be the main focused R&D center of Cardurion Pharmaceuticals and is also the origin country of the firm. Cardurion Pharmaceuticals was founded in the year 2017 by Michael Mendelsohn. Cardurion is a company that creates pharmaceuticals for the treatment of cardiovascular illnesses including heart failure. Do read about some of the most popular patents of Cardurion Pharmaceuticals which have been covered by us in this article and also you can find Cardurion Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cardurion Pharmaceuticals patent portfolio.
How many patents does the founder and the CEO of Cardurion Pharmaceuticals have?
The founder, Michael Mendelsohn, has 0 patents. The CEO, Pete Lawrence, has 0 patents.
How many patents does Cardurion Pharmaceuticals have?
Cardurion Pharmaceuticals has a total of 77 patents globally. These patents belong to 13 unique patent families. Out of 77 patents, 59 patents are active.
How Many Patents did Cardurion Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Cardurion Pharmaceuticals Applications Filed | Cardurion Pharmaceuticals Patents Granted |
| 2022 | 1 | 2 |
| 2021 | 20 | 3 |
| 2020 | 12 | 3 |
| 2019 | 24 | – |
| 2018 | 9 | – |
| 2017 | 6 | – |
How many Cardurion Pharmaceuticals patents are Alive/Dead?
Worldwide Patents 
How Many Patents did Cardurion Pharmaceuticals File in Different Countries?
Countries in which Cardurion Pharmaceuticals Filed Patents
| Country | Patents |
| United States Of America | 16 |
| Australia | 6 |
| Canada | 6 |
| Europe | 5 |
| Japan | 4 |
| South Africa | 3 |
| China | 3 |
| Taiwan | 3 |
| Brazil | 3 |
| Israel | 3 |
| Mexico | 3 |
| Indonesia | 2 |
| India | 2 |
| Singapore | 2 |
| New Zealand | 2 |
| Korea (South) | 1 |
| Colombia | 1 |
| Malaysia | 1 |
| Viet Nam | 1 |
| Chile | 1 |
| Austria | 1 |
| Hong Kong (S.A.R.) | 1 |
| Peru | 1 |
| Philippines | 1 |
Where are Research Centres of Cardurion Pharmaceuticals Patents Located?
10 Best Cardurion Pharmaceuticals Patents
WO2018183112A1 is the most popular patent in the Cardurion Pharmaceuticals portfolio. It has received 15 citations so far from companies like Gilead Sciences. Below is the list of 10 most cited patents of Cardurion Pharmaceuticals:
| Publication Number | Citation Count |
| WO2018183112A1 | 15 |
| WO2018009899A1 | 3 |
| US10543212B2 | 2 |
| CN110799190A | 2 |
| US11370795B2 | 1 |
| US20220098207A1 | 1 |
| US20210177845A1 | 1 |
| US20210107911A1 | 1 |
| US20210085684A1 | 1 |
| US20220023302A1 | 1 |
What are Cardurion Pharmaceuticals key innovation segments?
What Technologies are Covered by Cardurion Pharmaceuticals?
The chart below distributes patents filed by Cardurion Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Cardurion Pharmaceuticals thinks it’s important to protect particular technology inventions.
R&D Focus: How has Cardurion Pharmaceuticals search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Cardurion Pharmaceuticals?